bioRxivImmunologyPreprint
Antiviral innate immune memory in alveolar macrophages following SARS-CoV-2 infection.
A. Lercher, J.-G. Cheong, C. Jiang, H.-H. Hoffmann, A. W. Ashbrook, Y. S. Yin, C. Quirk, E. J. DeGrace, L. Chiriboga, B. R. Rosenberg, S. Z. Josefowicz, C. M. Rice
Abstract
Pathogen encounter results in long-lasting epigenetic imprinting that shapes diseases caused by heterologous pathogens. The breadth of this innate immune memory is of particular interest in the context of respiratory pathogens with increased pandemic potential and wide-ranging impact on global health. Here, we investigated epigenetic imprinting across cell lineages in a disease relevant murine model of SARS-CoV-2 recovery. Past SARS-CoV-2 infection resulted in increased chromatin accessibility of type I interferon (IFN-I) related transcription factors in airway-resident macrophages. Mechanistically, establishment of this innate immune memory required viral pattern recognition and canonical IFN-I signaling and augmented secondary antiviral responses. Past SARS-CoV-2 infection ameliorated disease caused by the heterologous respiratory pathogen influenza A virus. Insights into innate immune memory and how it affects subsequent infections with heterologous pathogens to influence disease pathology could facilitate the development of broadly effective therapeutic strategies.
- organism: mouse
- assay: ChIP-seq
- assay: bulk RNA-seq
- research focus: chromatin & epigenetic regulation
- research focus: host-pathogen & immune response
- approach: statistical model
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- SARS-CoV-2 replication triggers an MDA-5-dependent interferon production which is unable to efficiently control replication
A. Rebendenne, A. L. Chaves Valadao, … C. Goujon·bioRxiv·Oct 28, 2020
- Macrophages govern antiviral responses in human lung tissues protected from SARS-CoV-2 infection
D. J. Kenney, A. K. O'Connell, … F. Douam·bioRxiv·Jul 17, 2021
- The inflammatory microenvironment of the lung at the time of infection governs innate control of SARS-CoV-2 replication
P. J. Baker, A. C. Bohrer, … K. D. Mayer-Barber·bioRxiv·Mar 27, 2024
- Different pattern of pre-existing SARS-COV-2 specific T cell immunity in SARS-recovered and uninfected individuals
N. Le Bert, A. T. Tan, … A. Bertoletti·bioRxiv·May 26, 2020
- Persistent Cellular Immunity to SARS-CoV-2 Infection
G. Breton, P. Mendoza, … M. C. Nussenzweig·bioRxiv·Dec 8, 2020
- Evidence for Deleterious Antigenic Imprinting in SARS-CoV-2 Immune Response
S. R. Sen, E. C. Sanders, … G. A. Weiss·bioRxiv·May 21, 2021